Dear All,
I have had the following communication from NICE regarding the likely date that we will hear about the outcome of the March ACD meeting and resultant FAD. It looks like we will not hear anything until after May 10th at the earliest.
Sandy
'.....In order to avoid providing a focus for political debate or detract attention from the general election campaign, NICE will not publish any guidance document, either in draft or final form, after the announcement of the general election. Consultations that have started before the election is called will continue as planned. Not publishing guidance during the election period will not significantly lengthen NICE’s decision-making for guidance currently in development. As a result, the Institute has decided that until Monday 10 May 2010, it will not:
- issue any draft or final guidance documents (i.e. Appraisal Consultation Documents and Final Appraisal Determinations) for consultation
- publish any guidance.
This action, as you will appreciate, has the effect of materially delaying work in progress on the appraisal ofDasatinib and nilotinib for imatinib-intolerant chronic myeloid leukaemia.'